Related Experiment Video
Updated: Jun 24, 2026

Transesophageal Atrial Burst Pacing for Atrial Fibrillation Induction in Rats
Published on: February 14, 2022
Redox regulation, NF-kappaB, and atrial fibrillation
1Section of Cardiology, University of Illinois at Chicago, and the Jesse Brown VA Medical Center, Chicago, Illinois 60612, USA.
Insights
Atrial fibrillation (AF) management is challenged by poorly understood pathogenesis. Nuclear factor-kappaB (NF-kappaB) activation by oxidative stress may drive AF-related gene changes, offering a new therapeutic target.
Area of Science:
- Cardiology
- Molecular Biology
- Electrophysiology
Background:
- Atrial fibrillation (AF) is a common arrhythmia linked to stroke and heart failure.
- Current AF treatments focus on rate control and anticoagulation, with limited success in arrhythmia suppression.
- The underlying mechanisms of AF, particularly remodeling, are not fully understood.
Purpose of the Study:
- To investigate the role of oxidative stress and nuclear factor-kappaB (NF-kappaB) in AF pathogenesis.
- To explore NF-kappaB as a potential mediator of structural and electrical remodeling in AF.
- To identify novel therapeutic targets for AF management.
Main Methods:
- Review of recent findings on AF pathogenesis, including structural and electrical remodeling.
- Analysis of the link between oxidative stress, redox imbalance, and gene regulation in AF.
- Examination of the function of NF-kappaB in response to oxidative stress in cardiac cells.
Main Results:
- AF involves structural and electrical remodeling driven by altered gene regulation.
- Oxidative stress and redox imbalance are associated with AF.
- NF-kappaB, a redox-sensitive transcription factor, downregulates cardiac sodium channels under oxidative stress.
Conclusions:
- NF-kappaB activation by oxidative stress is a potential mechanism perpetuating AF.
- NF-kappaB may regulate other AF-associated factors, including ion channels and transcription factors.
- Targeting NF-kappaB presents a promising therapeutic strategy for managing atrial fibrillation.
Abstract:
Atrial fibrillation (AF) is the most common clinically encountered abnormal heart beat. It is associated with an increased risk of stroke and symptoms of heart failure. Current therapies are directed toward controlling the rate of ventricular activation and preventing strokes through anticoagulation. Attempts at suppressing the arrhythmia are often ineffective, in part because the underlying pathogenesis is poorly understood. Recently, structural and electrical remodeling has been shown to occur during AF. These changes involve alterations in gene regulation and help perpetuate the arrhythmia. Some signals for remodeling are have been identified. Moreover, AF is associated with oxidative stress, and this redox imbalance may contribute to the altered gene regulation. One likely mediator of this change in transcriptional regulation is the redox sensitive transcription factor, nuclear factor-kappaB (NF-kappaB). Recently, NF-kappaB has been shown to downregulate transcription of the cardiac sodium channel in response to oxidative stress. NF-kappaB may contribute to the regulation of other ion channels, transcription factors, or splicing factors altered in AF and may represent a therapeutic target in AF management.
Related Concept Videos
Redox Reactions
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Regulation of Heart Rates
The SNS increases heart rate through the release of norepinephrine and epinephrine, which act on beta-1 adrenergic receptors in the heart. This action increases the rate of depolarization in the sinoatrial (SA) node, the heart's...
Oxidation of Phenols to Quinones
o-hydroxy phenols are oxidized to o-quinones and p-hydroxy phenols to p-quinones. Such redox reactions involve the transfer of two electrons and two protons. The reversible redox property is crucial in...
